Patents by Inventor Nicole Wilb

Nicole Wilb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purine derivatives and their use for treatment of autoimmune diseases
    Patent number: 8080555
    Abstract: Compounds useful in the treatment of autoimmune disease are described by the following general formula: n=0-2 m=0-2 m is not necessarily equal to n; where R1, R3?NH2, F, Cl, C1-C4 alkoxy or phenoxy group, but R1 is not necessarily equal to R3; and R2?H, F, Cl, NH2, or NH—R—XH;
    Type: Grant
    Filed: May 15, 2006
    Date of Patent: December 20, 2011
    Assignee: Prometic Biosciences Inc.
    Inventors: Boulos Zacharie, Daniel Fortin, Nicole Wilb, Christopher Penney
  • Triazine dimers for the treatment of autoimmune diseases
    Patent number: 7683061
    Abstract: Compounds containing two mono- or disubstituted triazine rings covalently linked by an organic linker, but not linked directly to each other, may be used to treat autoimmune diseases. Autoimmune diseases which are amenable to treatment with compounds of this invention include rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis. The present invention also relates to reducing drug toxicity which often accompanies traditional therapies for autoimmune diseases. The compounds may also be used to bind antibody in vitro or ex vivo.
    Type: Grant
    Filed: November 22, 2004
    Date of Patent: March 23, 2010
    Assignee: ProMetic BioSciences Inc.
    Inventors: Christopher Penney, Boulos Zacharie, Shaun D. Abbott, Jean-François Bienvenu, Alan D. Cameron, Jean-Simon Duceppe, Abdallah Ezzitouni, Daniel Fortin, Karine Houde, Nancie Moreau, Nicole Wilb, Brigitte Grouix, Lyne Gagnon
  • 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use
    Publication number: 20090068169
    Abstract: The present invention describes new compounds which are useful for binding to the tail or Fc portion of immunoglobulins and so have utility in those applications which require the non-covalent binding interaction of a molecule with the Fc portion of immunoglobulins. Such applications include the detection and purification of immunoglobulins as well as the treatment of certain autoimmune diseases.
    Type: Application
    Filed: September 2, 2005
    Publication date: March 12, 2009
    Inventors: Christopher Penney, Boulos Zacharie, Shaun D. Abbott, Jean-Francois Bienvenu, Alan D. Cameron, Jean-Simon Duceppe, Abdallah Ezzitouni, Daniel Fortin, Karine Houde, Nancie Moreau, Nicole Wilb, Brigitte Grouix, Lyne Gagnon
  • Purine derivatives and their use for treatment of autoimmune diseases
    Publication number: 20090042768
    Abstract: Compounds useful in the treatment of autoimmune disease are described by the following general formula: n=0-2 m=0-2 m is not necessarily equal to n; where R1, R3?NH2, F, Cl, C1-C4 alkoxy or phenoxy group, but R1 is not necessarily equal to R3; and R2?H, F, Cl, NH2, or NH—R—XH; X?CH2,NH, O, or S.
    Type: Application
    Filed: May 15, 2006
    Publication date: February 12, 2009
    Inventors: Boulos Zacharie, Daniel Fortin, Nicole Wilb, Christopher Penney
  • Triazine dimers for the treatment of autoimmune diseases
    Publication number: 20070149528
    Abstract: Compounds containing two mono- or disubstituted triazine rings covalently linked by an organic linker, but not linked directly to each other, may be used to treat autoimmune diseases. Autoimmune diseases which are amenable to treatment with compounds of this invention include rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic (immune) thrombocytopenia (ITP), glomerulonephritis and vasculitis. The present invention also relates to reducing drug toxicity which often accompanies traditional therapies for autoimmune diseases. The compounds may also be used to bind antibody in vitro or ex vivo.
    Type: Application
    Filed: November 22, 2004
    Publication date: June 28, 2007
    Inventors: Christopher Penney, Boulos Zacharie, Shaun Abbott, Jean-Francois Bienvenu, Alan Cameron, Jean-Simon Duceppe, Abdallah Ezzitouni, Daniel Fortin, Karine Houde, Nancia Moreau, Nicole Wilb, Brigitte Grouix, Lyne Gagnon